Abstract:
The problem of studying the features of the dynamics of neurological defcit and cognitive
functions in the early recovery period in post-COVID patients with IS and optimizing therapy is becoming of national importance and an urgent need.
Purpose of the Study: To study the features of the dynamics of neurological defcit and higher brain functions in the early recovery period of ischemic stroke in post-COVID patients, with an assessment of the effectiveness of modifed drug and non-drug programs of rehabilitation therapy.
Materials and Research Methods: A total of 80 patients took part in the clinical study. The
patients were divided into 2 groups. Group 1 - post-COVID patients with IS, Group 2 - nonCOVID patients with IS.
Results: The inclusion of ethylmethylhydroxypyridine succinate and rivaroxaban in standard therapy met expectations and showed its positive role in reducing the recovery time of patients' functions, as determined using BDNF and cortisol biomarkers, as well as using data from the Rankin, Rivermead, MoCa and NIHHS scales.
Conclusion: Based on the results of the obtained data, the effectiveness of the approved therapy in the rehabilitation of post-COVID patients with ischemic stroke was established.
